TFS Financial officer sells 10,000 shares
TFS Financial Corp Chief Synergy Officer Cathy W. Zbanek reported an open-market sale of 10,000 shares of common stock at $15.26 per share on May 18, 2026.
Rhea-AI Filing Summary
TFS Financial Corp Chief Synergy Officer Cathy W. Zbanek reported an open-market sale of 10,000 shares of common stock at $15.26 per share on May 18, 2026. After this sale, she directly holds 61,101 common shares, along with additional indirect holdings through an ESOP and a 401(k) plan.
The filing also shows substantial outstanding equity awards, including stock options exercisable at $19.31 and $14.74 per share, and multiple grants of restricted and performance stock units that each convert into one share of common stock when they vest, some in equal annual installments beginning in December 2024, 2025, and 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10,000 shares
Net Sell
9 txns
Insider
Zbanek Cathy W
Role
Chief Synergy Officer
Sold
10,000 shs ($153K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $15.26 | $153K |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Restricted Share Units | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 61,101 shares (Direct);
Restricted Stock Units — 31,134 contracts (Direct);
Performance Restricted Share Units — 12,400 contracts (Direct);
Employee Stock Option (right to buy) — 266,900 contracts (Direct);
Common Stock — 5,323 shares (Indirect, By 401(k));
Common Stock — 14,234 shares (Indirect, By ESOP)
Footnotes (8)
- F1. Reflects transactions not required to be reported under Section 16 of the Securities Exchange Act, as amended.
- F2. Each restricted and performance stock unit represents a contingent right to receive one share of TFS Financial Corporation common stock. Restricted and performance stock units are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock.
- F3. On December 18, 2025, the reporting person received a grant of 15,800 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2026.
- F4. On March 4, 2024, the reporting person received a grant of 14,200 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2024.
- F5. On December 19, 2024, the reporting person received a grant of 15,900 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2025.
- F6. On November 25, 2025, the reporting person achieved performance level of 100% on a target award of 12,400 Performance Share Units ("PSUs"), resulting in a total earned award of 12,400 shares. This represents the final determination a March 4, 2024 award that was dependent on certain performance results during the two fiscal year period ended September 30, 2025. Each PSU represents a contingent right to receive one share of TFS Financial Corporation common stock and are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock during the period the award was outstanding. The shares and dividend equivalent payment will vest and distribute to the reporting person on December 10, 2026.
- F7. As reported on a Form 4 dated January 8, 2018, the reporting person received a grant of 187,500 stock options. These stock options vest in three equal annual installments beginning December 10, 2018.
- F8. As reported on a Form 4 dated December 15, 2016, the reporting person received a grant of 79,400 stock options. These stock options vest in three equal annual installments beginning December 10, 2017.
Key Figures
Shares sold: 10,000 shares
Sale price: $15.26 per share
Direct shares after sale: 61,101 shares
+5 more
8 metrics
Shares sold
10,000 shares
Common Stock sold at $15.26 per share on May 18, 2026
Sale price
$15.26 per share
Open-market or private sale of 10,000 common shares
Direct shares after sale
61,101 shares
Common Stock directly owned following the May 18, 2026 transaction
ESOP holdings
14,234 shares
Common Stock held indirectly through ESOP
401(k) holdings
5,323 shares
Common Stock held indirectly through 401(k)
Stock options 2026 expiry
79,400 shares at $19.31
Employee stock options expiring December 15, 2026
Stock options 2028 expiry
187,500 shares at $14.74
Employee stock options expiring January 5, 2028
Performance share units
12,400 units
Performance units earned at 100% of target, vesting December 10, 2026
Key Terms
Employee Stock Option (right to buy), Restricted Stock Units, Performance Restricted Share Units, dividend equivalent rights, +1 more
5 terms
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent rights financial
"entitled to dividend equivalent rights in the form of a cash payment"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
Section 16 of the Securities Exchange Act regulatory
"transactions not required to be reported under Section 16 of the Securities Exchange Act"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TFS Financial (TFSL) report for Cathy W. Zbanek?
TFS Financial reported that Chief Synergy Officer Cathy W. Zbanek sold 10,000 shares of common stock at $15.26 per share on May 18, 2026. This was an open-market or private transaction, leaving her with 61,101 directly held shares afterward.
What stock options does Cathy Zbanek have outstanding in TFS Financial (TFSL)?
Cathy Zbanek holds employee stock options covering 79,400 shares at a $19.31 exercise price expiring December 15, 2026, and 187,500 shares at a $14.74 exercise price expiring January 5, 2028. These options were originally granted in 2016 and 2018 and vest in three annual installments.
What restricted stock units does Cathy Zbanek hold in TFS Financial (TFSL)?
She holds several restricted stock unit awards, including 15,800 RSUs granted December 18, 2025, vesting in three equal annual installments beginning December 10, 2026. Additional RSU grants from March 4, 2024 and December 19, 2024 also vest in three equal annual installments starting in 2024 and 2025.
Do Cathy Zbanek’s TFS Financial (TFSL) stock units receive dividends?
Yes. The filing states each restricted and performance stock unit carries dividend equivalent rights. She receives cash payments equal to any cash dividend paid per share of common stock while these awards are outstanding, in addition to eventual share delivery at vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
